Cramer's Morning Take: Microsoft & Viking Therapeutics 3/26/24
b'Jim and Jeff discuss the analyst price target increase for Microsoft. They also talk about the weight loss drug opportunity for Viking Therapeutics. Become a CNBC Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks as they talk candidly about the market\\u2019s biggest headlines. Signup here: cnbc.com/morningtake \\nCNBC Investing Club Disclaimer'